The synthesis of oligonucleotides was performed via MerMade 12 solid phase synthesis with phosphoramidites. All oligonucleotides (DNA, modified DNA, 2'OMeRNA, 2'OMeRNA-LNA) were deprotected according to published procedure49,50. To solid support was added 32% ammonia solution and incubated in 55 °C, 18 h, than evaporated and dissolved in water. Primers for reverse transcription, contained C6-aminolinker at 5′-end, were treated, in next step, with 80% acetic acid (3 h), precipitated in 1% sodium perchlorate solution in acetone and labelled with 5-FAM, 6-JOE, 5-ROX or 6-TAMRA (Anaspec). 300 µg of oligonucleotide was dissolved in water (11 µl) and 75 µl of 0.1M sodium tetraborate, pH 8.5 and fluorophore [TAMRA, FAM (200 µg) or JOE, ROX (250 µg)] in 14 µl DMSO was added. Reactions were incubated at 23 °C for 18 h by slowly mixing (150 rpm) then precipitated and run on 12% denaturing PAA gel. Oligonucleotides for ribonuclease H assay were purified using thin layer chromatography (TLC) and mobile phase was n-propanol/ammonia/water (52/35/13). Antisense oligonucleotides (2′-O-methyl RNA and 2′-O-methyl RNA containing LNA modifications (LNA - locked nucleic acids) were purified with TLC (short oligonucleotides) or denaturing 12% PAA gel (oligonucleotides longer than 11 nt). Oligonucleotides concentration was measured at 260 nm with Nanodrop spectrophotometer (Thermo Scientific). Molecular weights were confirmed by mass spectrometry (MALDI TOF, Autoflex, Brucker).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.